Cytel Reveals New Software and Statistical Methods Research Advances at JSM Denver/2008
Life sciences statistical community previews elements™ - Cytel's new clinical trial software, together with latest East® additions at conference talks, workshops and on the exhibit floor
Denver, CO, August 03, 2008 - At this year's annual Joint Statistical Meetings, August 2nd to August 7th, experts from Cytel are conducting workshops to examine the new capabilities of Cytel's clinical trial design and analysis software tools.
Cytel and its industry and academia research partners continue to innovate the clinical development process through statistical methods research and increasing implementation of new trial approaches. Recent statistical methods advances are responsible for the growing utilization of adaptive clinical trials (ACTs), Bayesian statistics designs, and the advent of trial simulation and supply forecast modeling technologies.
The American Statistical Association's annual JSM is the largest gathering of life sciences statisticians. At JSM 2008, three Cytel workshops bring together the statisticians who use and statisticians that make Cytel software:
Cyrus Mehta, president and co-founder of Cytel presents "East®Adapt: A Module for Late-Stage Adaptive Trial Design Within the East® 5 Software System"
Senior Statistician Yannis Jemiai and Vice President of Product Development Pralay Senchaudhuri demonstrate "elements™: New Software for the Design, Analysis, and Reporting of Bioequivalence and Clinical Pharmacology Trials"
Director of QA and Clinical Research Services Anthiyur Kannappan and Pralay Senchaudhuri will present "Exact Methods Module for East® 5: Design, Simulate, Analyze, and Monitor Binomial Endpoint Trials by Exact Inference Methods"
For the complete JSM conference schedule, visit the JSM 2008 website
About Cytel
Cytel Inc. is a leading provider of clinical trial design services and specialized statistical software for the biopharmaceutical, medical device, academic, and government research markets. Cytel’s East® system is used at hundreds of commercial sites, throughout academia, and by regulators to design, simulate and monitor adaptive and group sequential clinical trials. Cytel provides trial sponsors with innovative tools, training and consultation to increase the return on investment in clinical development.
For interview requests, product images or information, contact:
Michael Weitz
Marketing Director
617.661.2011
mike@cytel.com